Press Room

IPAC-RS FDA Roundtable

Start
Monday, November 02, 2020 - 10:30
End
Monday, November 02, 2020 - 10:30
Location: online
IPAC-RS Logo | Hovione

 

 

On November 2, 2020, (10:30 AM – 12:00 PM US ET) IPAC-RS is hosting a webinar with FDAA Conversation with the FDA: Perspectives in the Time of COVID-19. Carla Vozone, Vice President, Pharmaceutical Development & Licensing at Hovione is a panelist in this discussion.

 

Click Here to Register Now

 

 

The IPAC-RS Regulatory Roundtable Series is focused on bringing together leaders in the Orally Inhaled and Nasal Drug Product (OINDP) space. Invited guests will include regulators, industry thought leaders, business leaders, academics, patient groups and others who comprise the OINDP “ecosystem.”

PANELISTS

  • Richard Lostritto, Associate Director for Science in Office of Policy for Pharmaceutical Quality  (OPPQ)/OPQ/CDER/US Food and Drug Administration
  • Brian J. Hasselbalch, Deputy Director, OPPQ/OPQ/CDER/US Food and Drug Administration
  • Carla Vozone, Vice President, Pharmaceutical Development & Licensing, Hovione
  • Martin J. Oliver, Senior Vice President, Generic Programmes, Vectura Ltd.

MODERATOR

  • Mary Devlin Capizzi, IPAC-RS Secretariat and Legal Counsel; Partner, Faegre Drinker Biddle & Reath LLC

 

Click Here to Register Now

 

 

Registration is required to attend the webinar

After registering, individuals will receive a confirmation email containing a custom link* and additional information about joining the webinar.

 

Questions?

Please contact Mrs. Dede Godstrey at the IPAC-RS Secretariat at Dede.Godstrey@FaegreDrinker.com 

 

 

 

Click here to view Webinar Roundtable Flyer

Also in the Press Room

See All

In an interview with Executiva, a portuguese media outlet focused on women´s leadership, Diane Villax, co-founder and long-standing leader of Hovione, reflects on her journey and the company’s development over more than six decades. Diane Villax’s career began at a time when few women worked outside the home. At 19, she joined a trading company as a foreign languages correspondent, where she developed essential business skills — including commercial correspondence, banking and export procedures — that later proved instrumental in helping her husband, Ivan Villax, establish Hovione in 1959. From its earliest days operating in the family home in Lisbon, Hovione adopted an international outlook. The company’s first major customers were in Japan, setting demanding quality standards that helped shape its long-term position in global markets. Over the following decades, Hovione expanded its footprint with the construction of its first manufacturing site in Loures (1969), followed by expansion to Macau (1986), the United States (New Jersey, early 2000s) and Ireland (Cork). The company grew into a global organization with more than 2,500 employees — including over 300 scientists — and a reputation as a preferred supplier to leading pharmaceutical companies worldwide. Throughout the interview, Diane highlights the values that have guided the company’s development: a commitment to excellence, a strong work ethic, and a focus on quality and long-term relationships. Although she did not have formal business training, she learned “on the job” and brought discipline, precision and structure to her role — particularly in the company’s early financial and administrative leadership. Now in her nineties and an active member of Hovione’s Board of Directors, Diane Villax remains engaged with the company’s evolution and governance, reflecting a continued commitment to its long-term development. Her story reflects entrepreneurial drive, resilience and long-term leadership — and offers insight into the values that have shaped Hovione’s trajectory for more than six decades. Read the full interview at Executiva.pt (in portuguese).    

Article

Hovione’s Diane Villax: “I was not brought up to be a business woman”

Feb 23, 2026